Trials / Completed
CompletedNCT02413567
Evaluation of Duodenal Mucosal Resurfacing in Subjects With Type 2 Diabetes
Evaluation of Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Fractyl Health Inc. · Industry
- Sex
- All
- Age
- 28 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the Fractyl Duodenal Mucosal Resurfacing (DMR) Procedure for the treatment of Type 2 Diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DMR Procedure (Fractyl) | Endoscopic procedure |
Timeline
- Start date
- 2015-03-23
- Primary completion
- 2017-06-12
- Completion
- 2019-09-18
- First posted
- 2015-04-10
- Last updated
- 2024-02-14
Locations
7 sites across 5 countries: Belgium, Chile, Italy, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT02413567. Inclusion in this directory is not an endorsement.